[New indications of ivermectin]
- PMID: 11586522
- DOI: 10.1016/s0248-8663(01)00350-2
[New indications of ivermectin]
Abstract
Introduction: Ivermectin is a semi-synthetic derivative of a family of macrocyclic lactones. This drug has a broad-spectrum anti-parasitic effect against various nematodes and ectoparasites. CURRENT KNOWLEDGE AND KEY-POINTS: Onchocerciasis and lymphatic filariasis are common indications. More recently ivermectin has been recommended in the treatment of strongyloidiasis and scabies.
Future prospects and projects: Promising results have been shown in the treatment of ascariasis, cutaneous larva migrans, loiasis and head lice.
Similar articles
-
Ivermectin in human medicine, an overview of the current status of its clinical applications.Curr Pharm Biotechnol. 2012 May;13(6):1103-9. doi: 10.2174/138920112800399248. Curr Pharm Biotechnol. 2012. PMID: 22039800 Review.
-
[Indication of Mectizan in human medicine other than onchocerciasis].Sante. 1998 Jan-Feb;8(1):84-7. Sante. 1998. PMID: 9592892 French. No abstract available.
-
[Ivermectin and tropical dermatoses].Bull Soc Pathol Exot. 1997;90(1):37-8. Bull Soc Pathol Exot. 1997. PMID: 9264749 Review. French.
-
Ivermectin: pharmacology and application in dermatology.Int J Dermatol. 2005 Dec;44(12):981-8. doi: 10.1111/j.1365-4632.2004.02253.x. Int J Dermatol. 2005. PMID: 16409259 Review.
-
Ivermectin in dermatology.J Drugs Dermatol. 2003 Jan;2(1):13-21. J Drugs Dermatol. 2003. PMID: 12852376 Review.
Cited by
-
Anti-inflammatory effects of ivermectin in mouse model of allergic asthma.Inflamm Res. 2011 Jun;60(6):589-96. doi: 10.1007/s00011-011-0307-8. Epub 2011 Jan 29. Inflamm Res. 2011. PMID: 21279416
-
Treatment of loiasis: a review of clinical management recommendations.Infect Dis Poverty. 2025 May 7;14(1):35. doi: 10.1186/s40249-025-01300-0. Infect Dis Poverty. 2025. PMID: 40336051 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases